Burundi vs IDA blend: Access to anti-retroviral drugs, male
Burundi
90.0%
in 2024
IDA blend
74.0%
in 2024
Burundi rank
13th
IDA blend rank
14th
Access to anti-retroviral drugs, male over time
- Burundi
- IDA blend
How they compare
Burundi currently reports 90.0% against 74.0% in IDA blend, a difference of 16.0%.
That makes Burundi's figure about 1.2 times IDA blend's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was IDA blend ahead.
Burundi ranks 13th and IDA blend ranks 14th of 141 countries.
Burundi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.8% | 5.5% | 1.3% | Burundi |
| 2010s | 45.6% | 38.5% | 7.1% | Burundi |
| 2020s | 85.4% | 67.7% | 17.7% | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Burundi or IDA blend?
- Burundi, at 90.0% against 74.0% in IDA blend as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Burundi and IDA blend?
- 16.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and IDA blend?
- 25 years are reported by both, from 2000 to 2024.
- How do Burundi and IDA blend rank globally for access to anti-retroviral drugs, male?
- Burundi ranks 13th and IDA blend ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.